UMass Medical School is at the center of a growing biomanufacturing initiative in Worcester and is key to providing access to top-tier resources not available elsewhere according to a recent article about the next phase of investment for the Massachusetts Life Sciences Center.
Worcester Business Journal
Toxicologist Edward Boyer, MD, PhD, professor of emergency medicine, explains how Erowid, repository of drug-culture esoterica on the Internet, changed how toxicologists learn the street names of unfamiliar drugs, along with the basic chemicals that they contained.
The New Yorker
An article about excessive wait times experienced by Central Massachusetts veterans seeking health care includes comments from Veterans Affairs Central Western Massachusetts Healthcare System Director John P. Collins regarding his support for a partnership with UMass Medical School proposed in 2014.
Worcester Telegram & Gazette
David Paydarfar, MD, professor and vice chair of neurology, has developed a vibration-based prevention technology that has been shown to reduce apneic events in a neonatal intensive care unit (NICU) and improves critical clinical parameters in prematurely born infants.
Rita Bortell, PhD, research professor of molecular medicine, and Agata Jurczyk, PhD, instructor in molecular medicine, have discovered that a shared gene (or genes) may underlie the co-occurrence of schizophrenia and diabetes.
Michael P. Hirsh, MD, professor of pediatric surgery, chief of pediatric surgery & trauma and Worcester’s interim commissioner of public health, advocates that lawmakers support a bill that would allow police officers to pull over drivers for not wearing seat belts.
State House News Service
An op-ed by Chancellor Michael Collins, MD, discusses how Massachusetts is combatting the opioid crisis and the role UMass Medical School plays in that fight.
Worcester Telegram and Gazette
Scot Wolfe, PhD, associate professor of molecular, cell & cancer biology, has developed a new CRISPR technology that is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Gyongyi Szabo, MD, PhD, professor of medicine, is quoted in an article about a promising investigational drug combination being used to treat patients with hepatitis C.
Joyce A. Murphy, MPA, executive vice chancellor of UMass Medical School’s Commonwealth Medicine division, is quoted in an article about the newly opened MassOptions, which connects elders, individuals with disabilities and their caregivers with agencies and organizations that can best meet their needs.
Worcester Telegram & Gazette
Chancellor Michael Collins, MD, announced that it is immediately incorporating into its School of Medicine curriculum specific training in support of 10 agreed-upon core competencies for the prevention and management of prescription drug misuse.
Bonnie Greenwood, PharmD, BCPS, clinical program director of clinical pharmacy services, writes about how health plans can raise their Centers for Medicare and Medicaid Services (CMS) Star Ratings.
Kavita Babu, a toxicologist and associate professor of emergency medicine, describes the risks of prescribing medications in combination with an opiate and what physicians can do to minimize adverse interactions.
Bezlotoxumab, a fully-human monoclonal antibody, developed by researchers at the University of Massachusetts Medical School’s MassBiologics with Medarex (now part of Bristol-Myers Squibb), and licensed to Merck in 2009 is nearing FDA approval.
David McManus, MD, associate professor of medicine, and colleagues are working on ways to remotely and noninvasively monitor patients with serious cardiac disease in the hopes of keeping them healthier and preventing emergency room visits and hospitalizations.
Stephanie Carreiro, MD, instructor in emergency medicine, explains how a wrist bracelet now being tested at UMMS can be used to help treat recovering addicts.
A new survey developed by UMass Medical School (UMMS) and The Association of American Medical Colleges is being used to assess diversity in academic medical centers across the country.
A survey designed by a group of eight students from the University of Massachusetts Medical School Rural Health Scholars program is intended to help Dukes County quantify the homeless population on the Island.
Martha's Vineyard Times
Mark Klempner, MD, executive vice chancellor for MassBiologics and professor of medicine, explains how scientists at MassBiologics are developing a pre-exposure prophylaxis that prevents tick-transmitted infection of Lyme disease, a breakthrough that could lead to seasonal prevention against the most common tick-borne infection in North America.